Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Teva Pharmaceuticals USA, Inc. et al v. Sandoz, Inc. et al
Case Number:
1:08-cv-07611
Court:
Nature of Suit:
Judge:
Firms
- ArentFox Schiff
- Friedman Kaplan
- Giaccio LLC
- Gibson Dunn
- Goodwin Procter
- Morrison Foerster
- Perkins Coie
- Weil Gotshal
Companies
- Momenta Pharmaceuticals Inc.
- Novartis AG
- Sandoz International GmbH
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
-
February 11, 2015
Teva Loses Bid For Sales Ban On Generic Copaxone
A New York federal judge on Tuesday rejected Teva Pharmaceuticals USA Inc.'s bid to block sales of generic versions of its multiple sclerosis drug Copaxone following a recent U.S. Supreme Court patent decision, ruling that he had no authority to grant Teva's request.
-
February 02, 2015
Teva Asks Judge To Bar Generic Copaxone During Remand
Teva Pharmaceuticals USA Inc. asked a federal judge Friday to block sales of generic versions of its multiple sclerosis drug Copaxone during the remand of a recent U.S. Supreme Court ruling that vacated a decision invalidating a key patent covering the drug.
-
June 25, 2012
Mylan, Sandoz Infringed Teva's MS Drug Patents, Judge Finds
In a major win for Teva Pharmaceutical Industries Ltd., a judge has ruled that Mylan Pharmaceuticals Inc. and Sandoz Inc. infringed the Israeli drugmaker's patents for Copaxone in making generic versions of the multiple sclerosis drug.